Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
出版年份 2011 全文链接
标题
Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
作者
关键词
-
出版物
ANTIOXIDANTS & REDOX SIGNALING
Volume 15, Issue 9, Pages 2543-2563
出版商
Mary Ann Liebert Inc
发表日期
2011-04-04
DOI
10.1089/ars.2011.3965
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
- (2010) Christian Cadeddu et al. AMERICAN HEART JOURNAL
- Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
- (2010) William N. William et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase II Study of Paclitaxel and Irinotecan With Intercalated Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Fumihiro Oshita et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer
- (2010) Houman M. Fekrazad et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- H2O2 alters rat cardiac sarcomere function and protein phosphorylation through redox signaling
- (2010) Benjamin S. Avner et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness
- (2010) Laura A. A. Gilliam et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer
- (2010) Suresh S. Ramalingam et al. CANCER
- Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma
- (2010) Jia Ruan et al. CANCER
- Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement
- (2010) Apostolia M. Tsimberidou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma
- (2010) M. Honda et al. DISEASES OF THE ESOPHAGUS
- Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial
- (2010) M. Fabbro et al. GYNECOLOGIC ONCOLOGY
- Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel — pretreated ovarian carcinoma
- (2010) D. Pectasides et al. GYNECOLOGIC ONCOLOGY
- Cardiac side-effects of cancer chemotherapy
- (2010) Jean-Jacques Monsuez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
- (2010) Allan Lipton et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer
- (2010) David Loesch et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
- (2010) David R. Spigel et al. Journal of Thoracic Oncology
- Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer
- (2010) Benjamin Movsas et al. Journal of Thoracic Oncology
- A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer
- (2010) David R. Spigel et al. Journal of Thoracic Oncology
- Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy
- (2010) Laura A.A. Gilliam et al. MUSCLE & NERVE
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Oxidative stress in non-small cell lung cancer patients after chemotherapy: Association with treatment response
- (2010) Abhilasha GUPTA et al. RESPIROLOGY
- Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients With Advanced Solid Malignancies
- (2009) Daruka Mahadevan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase II Study of Epirubicin in Combination With Weekly Docetaxel for Patients With Advanced NSCLC Who Have Failed or Relapsed After the Frontline Platinum-Based Chemotherapy
- (2009) Chih-Ming Lin et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
- (2009) P. C. Enzinger et al. ANNALS OF ONCOLOGY
- Protein Carbonylation in Skeletal Muscles: Impact on Function
- (2009) Esther Barreiro et al. ANTIOXIDANTS & REDOX SIGNALING
- Irinotecan Side Effects Relieved by the Use of HI-6 Oxime:In VivoExperimental Approach
- (2009) Ana Lucić Vrdoljak et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration
- (2009) Dora Il’yasova et al. BIOMARKERS
- Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-Q
- (2009) Karunakaran Chandran et al. BIOPHYSICAL JOURNAL
- Direct effects of doxorubicin on skeletal muscle contribute to fatigue
- (2009) K van Norren et al. BRITISH JOURNAL OF CANCER
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- (2009) P N Munster et al. BRITISH JOURNAL OF CANCER
- Docetaxel and irinotecan in recurrent or metastatic head and neck cancer
- (2009) Athanassios Argiris et al. CANCER
- Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer
- (2009) S. H. Waters et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer
- (2009) Marika Crohns et al. CLINICAL BIOCHEMISTRY
- Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer
- (2009) Paul H Sugarbaker CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway
- (2009) Elizabeth D. Brookins Danz et al. FREE RADICAL BIOLOGY AND MEDICINE
- Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008
- (2009) Ali Montazeri Health and Quality of Life Outcomes
- Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle
- (2009) Laura A. A. Gilliam et al. JOURNAL OF APPLIED PHYSIOLOGY
- Feasibility Trial of Partial Breast Irradiation With Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early-Stage Breast Cancer
- (2009) Richard C. Zellars et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
- (2009) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m2Administered Weekly as a 30-Minute Intravenous Infusion in Patients With Cancer
- (2009) Kelly K. Curtis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer-Related Fatigue: Central or Peripheral?
- (2009) Tugba Yavuzsen et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment
- (2009) Gillian Prue et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Carnitine Plasma Levels and Fatigue in Children/Adolescents Receiving Cisplatin, Ifosfamide, or Doxorubicin
- (2009) Marilyn J. Hockenberry et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial
- (2009) Asher Chanan-Khan et al. LEUKEMIA & LYMPHOMA
- Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer
- (2009) Alberto Sobrero et al. ONCOLOGY
- Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic Cancer
- (2009) B. Neri et al. ONCOLOGY RESEARCH
- Differential Contractile Impairment of Fast- and Slow-Twitch Skeletal Muscles in a Rat Model of Doxorubicin-Induced Congestive Heart Failure
- (2009) Mert Ertunc et al. PHARMACOLOGY
- Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission
- (2008) Richard M. Stone et al. AMERICAN JOURNAL OF HEMATOLOGY
- Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study
- (2008) J. Rom et al. ANNALS OF ONCOLOGY
- Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2
- (2008) Nicole M. Diotte et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer
- (2008) Joseph S. Chan et al. BJU INTERNATIONAL
- Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
- (2008) Marjorie Zauderer et al. BREAST CANCER RESEARCH AND TREATMENT
- A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin
- (2008) Kurt Van der Speeten et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer
- (2008) Noelle K. LoConte et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer
- (2008) Se Hoon Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
- (2008) E. Claire Dees et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
- (2008) William R. Schelman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effects of Pyrrolidine Dithiocarbamate on Antioxidant Enzymes in Cardiomyopathy Induced by Adriamycin in Rats
- (2008) E. Mingyan et al. CARDIOLOGY
- Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes
- (2008) Yasuhiro Yamamoto et al. CARDIOVASCULAR RESEARCH
- Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data
- (2008) J. R. Molina et al. CLINICAL CANCER RESEARCH
- Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions
- (2008) Peter G Arthur et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer
- (2008) C. Sessa et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of epirubicin-induced acute oxidative stress toxicity in rat liver cells and mitochondria, and the prevention of toxicity through quercetin administration
- (2008) M. Kebieche et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers
- (2008) Robert Morris et al. GYNECOLOGIC ONCOLOGY
- Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
- (2008) William P. Tew et al. INVESTIGATIONAL NEW DRUGS
- Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
- (2008) H. Sayar et al. INVESTIGATIONAL NEW DRUGS
- TNF-α acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle
- (2008) Brian J. Hardin et al. JOURNAL OF APPLIED PHYSIOLOGY
- Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
- (2008) Vinay K. Puduvalli et al. NEURO-ONCOLOGY
- Persistence, Up to 18 Months of Follow-Up, of Epirubicin-Induced Myocardial Dysfunction Detected Early by Serial Tissue Doppler Echocardiography: Correlation with Inflammatory and Oxidative Stress Markers
- (2008) G. Mantovani et al. ONCOLOGIST
- Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
- (2008) Scott K. Powers et al. PHYSIOLOGICAL REVIEWS
- Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation
- (2008) D A Galvão et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Effects of N-acetylcysteine on respiratory muscle fatigue during heavy exercise
- (2008) Megan K. Kelly et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Functional, structural, and chemical changes in myosin associated with hydrogen peroxide treatment of skeletal muscle fibers
- (2007) Ewa Prochniewicz et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Cysteine-Rich Protein Reverses Weight Loss in Lung Cancer Patients Receiving Chemotherapy or Radiotherapy
- (2007) Richard G. Tozer et al. ANTIOXIDANTS & REDOX SIGNALING
- Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma
- (2007) Dimitrios Pectasides et al. GYNECOLOGIC ONCOLOGY
- Muscle-derived ROS and thiol regulation in muscle fatigue
- (2007) Leonardo F. Ferreira et al. JOURNAL OF APPLIED PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started